Nuclear receptors and their coactivators have been shown to function as key regulators of adipose tissue biology. Here we show that a ligand-dependent transcriptional repressor for nuclear receptors plays a crucial role in regulating the balance between energy storage and energy expenditure. Mice devoid of the corepressor protein RIP140 are lean, show resistance to high-fat diet-induced obesity and hepatic steatosis, and have increased oxygen consumption. Although the process of adipogenesis is unaffected, expression of certain lipogenic enzymes is reduced. In contrast, genes involved in energy dissipation and mitochondrial uncoupling, including uncoupling protein 1, are markedly increased. Therefore, the maintenance of energy homeostasis requires the action of a transcriptional repressor in white adipose tissue, and ligand-dependent recruitment of RIP140 to nuclear receptors may provide a therapeutic target in the treatment of obesity and related disorders. E nergy homeostasis is a highly regulated process that requires precise control of food intake and energy expenditure (1). The major and most efficient storage of energy occurs in the form of triglycerides in white adipose tissue (WAT), and it is now clear that the adipocyte itself may act as an endocrine cell such that altered adipocyte function would cause changes in systemic energy balance (2, 3). From adipogenic stores, fatty acids are easily mobilized during periods of energy restriction or increased physical activity to provide enough fuel for energy synthesis in the form of ATP. In addition, energy is dissipated by generating heat in brown adipose tissue (BAT) and skeletal muscles by regulating the uncoupling of ATP production from respiration. Many of these metabolic processes are controlled in part by nuclear receptors (4, 5), including peroxisome proliferatoractivated receptors (PPARs) (6, 7), thyroid hormone receptor (8, 9), estrogen receptor ␣ (ER␣) (10, 11), and ER-related receptor ␣ (ERR␣) (12). The best characterized of these are the PPARs, with PPAR␥ and PPAR␣ playing an essential role in adipogenesis (13-16) and in thermogenesis and fatty acid oxidation (17-19), respectively, whereas recent studies have implicated a role for PPAR␦ in lipid homeostasis (20).Nuclear receptors stimulate target gene transcription by recruiting coactivators that are required to remodel chromatin and facilitate the assembly of the basal transcription machinery (21). The key coactivator in metabolic processes is the PPAR␥ coactivator 1␣ (PGC-1␣) (22-25), which was initially shown to promote adaptive thermogenesis in BAT and which has emerged as a target for integrating signals in the regulation of specific metabolic programs in other tissues, including muscle and liver. More recently, the related coactivator PGC-1␤ (26, 27) has been implicated in the regulation of energy expenditure as a potential coactivator for ERR␣ (28). In addition, the p160 family of coactivators has also been found to control energy balance in adipose tissue. For instance, SRC1, in associatio...

Peroxisome proliferator activated receptor gamma 2 (PPARg2) is the nutritionally regulated isoform of PPARg. Ablation of PPARg2 in the ob/ob background, PPARg2−/− Lepob/Lepob (POKO mouse), resulted in decreased fat mass, severe insulin resistance, β-cell failure, and dyslipidaemia. Our results indicate that the PPARg2 isoform plays an important role, mediating adipose tissue expansion in response to positive energy balance. Lipidomic analyses suggest that PPARg2 plays an important antilipotoxic role when induced ectopically in liver and muscle by facilitating deposition of fat as relatively harmless triacylglycerol species and thus preventing accumulation of reactive lipid species. Our data also indicate that PPARg2 may be required for the β-cell hypertrophic adaptive response to insulin resistance. In summary, the PPARg2 isoform prevents lipotoxicity by (a) promoting adipose tissue expansion, (b) increasing the lipid-buffering capacity of peripheral organs, and (c) facilitating the adaptive proliferative response of β-cells to insulin resistance.